Genome-Wide Testing of Putative Functional Exonic Variants in Relationship with Breast and Prostate Cancer Risk in a Multiethnic Population

PLoS Genetics

Volumn 9, Issue 3, 2013, Pages

  Haiman, Christopher A ^a   Han, Ying ^a   Feng, Ye ^a   Xia, Lucy ^a   Hsu, Chris ^a   Sheng, Xin ^a   Pooler, Loreall C ^a   Patel, Yesha ^a   Kolonel, Laurence N ^b   Carter, Erin ^a   Park, Karen ^a   Le Marchand, Loic ^b   Van Den Berg, David ^a   Henderson, Brian E ^a   Stram, Daniel O ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGED; ANXA4 GENE; ARTICLE; ASIAN AMERICAN; BODY MASS; BREAST CANCER; CANCER RISK; CASP5 GENE; CONTROLLED STUDY; DRINKING BEHAVIOR; ETHNIC GROUP; EUROPEAN AMERICAN; F13A1 GENE; FEMALE; FGFBP3 GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GP6 GENE; GPRC6A GENE; HIGH RISK POPULATION; HISPANIC; HUMAN; INS IGF2 GENE; LDLRAD1 GENE; MALE; MANSC1 GENE; MMAB GENE; NATIVE HAWAIIAN; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SLC16A6 GENE; SLC19A1 GENE;

AFRICAN AMERICANS; AGED; ALLELES; ASIAN AMERICANS; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84875982465     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003419     Document Type: Article

References (48)

1. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA, (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33: D514-517.
2. Stratton MR, Rahman N, (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40: 17-22.
3. Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, et al. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat Genet 43: 879-882.
4. Rafnar T, Gudbjartsson DF, Sulem P, Jonasdottir A, Sigurdsson A, et al. Mutations in BRIP1 confer high risk of ovarian cancer. Nat Genet 43: 1104-1107.
5. Johansen CT, Wang J, Lanktree MB, Cao H, McIntyre AD, et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 42: 684-687.
6. Fearnhead NS, Wilding JL, Winney B, Tonks S, Bartlett S, et al. (2004) Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci U S A 101: 15992-15997.
7. Sulem P, Gudbjartsson DF, Walters GB, Helgadottir HT, Helgason A, et al. Identification of low-frequency variants associated with gout and serum uric acid levels. Nat Genet 43: 1127-1130.
8. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066-1073.
9. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, et al. (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72: 1-12.
10. Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, et al. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int 107: 28-39.
11. Sobrin L, Ripke S, Yu Y, Fagerness J, Bhangale TR, et al. (2012) Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology 119: 1874-1885.
12. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, et al. (2011) New gene functions in megakaryopoiesis and platelet formation. Nature 480: 201-208.
13. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, et al. (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137-141.
14. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
15. Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, et al. (2007) A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448: 591-594.
16. Postel-Vinay S, Veron AS, Tirode F, Pierron G, Reynaud S, et al. (2012) Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 44: 323-327.
17. Lin LL, Huang HC, Juan HF, (2012) Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays. PLoS ONE 7: e44615 doi:10.1371/journal.pone.0044615.
18. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, et al. (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 42: 751-754.
19. Michailidou K, Hall P, Gonzalez-Niera A, Ghoussaini M, Dennis J, et al. (2013) Large-scale genotyping identifies 38 new breast cancer susceptibility loci. In press for Nature Genetics.
20. Eeles RA, Olama AAA, Benlloch S, Saunders EJ, Leongamornlert DA, et al. (2013) Identification of 23 novel prostate cancer susceptibility loci using a custom array (the iCOGS) in an international consortium, PRACTICAL. In press for Nature Genetics.
21. Chen F, Stram DO, Le Marchand Loïc, Monroe KR, Kolonel LN, et al. (2010) Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations. Eur J Hum Genet 19: 243-245.
22. Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, et al. (2012) Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med 366: 141-149.
23. Takeuchi F, Isono M, Nabika T, Katsuya T, Sugiyama T, et al. (2011) Confirmation of ALDH2 as a Major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population. Circ J 75: 911-918.
24. Parikh H, Wang Z, Pettigrew KA, Jia J, Daugherty S, et al. (2011) Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet 129: 675-685.
25. Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, et al. (2010) Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med 2: 62ra92.
26. Klein RJ, Hallden C, Cronin AM, Ploner A, Wiklund F, et al. (2010) Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer. Cancer Prev Res (Phila) 3: 611-619.
27. Bouchard L, Faucher G, Tchernof A, Deshaies Y, Marceau S, et al. (2009) Association of OSBPL11 gene polymorphisms with cardiovascular disease risk factors in obesity. Obesity (Silver Spring) 17: 1466-1472.
28. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, et al. (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 43: 55-59.
29. Laramie JM, Wilk JB, Williamson SL, Nagle MW, Latourelle JC, et al. (2008) Polymorphisms near EXOC4 and LRGUK on chromosome 7q32 are associated with Type 2 Diabetes and fasting glucose; the NHLBI Family Heart Study. BMC Med Genet 9: 46.
30. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB, (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294 doi:10.1371/journal.pbio.1000294.
31. Gibson TM, Brennan P, Han S, Karami S, Zaridze D, et al. (2011) Comprehensive evaluation of one-carbon metabolism pathway gene variants and renal cell cancer risk. PLoS ONE 6: e26165 doi:10.1371/journal.pone.0026165.
32. Dong LM, Brennan P, Karami S, Hung RJ, Menashe I, et al. (2009) An analysis of growth, differentiation and apoptosis genes with risk of renal cancer. PLoS ONE 4: e4895 doi:10.1371/journal.pone.0004895.
33. Hanlon K, Rudin CE, Harries LW, (2009) Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL). PLoS ONE 4: e7169 doi:10.1371/journal.pone.0007169.
34. Pi M, Quarles LD, (2012) GPRC6A regulates prostate cancer progression. Prostate 72: 399-409.
35. Pi M, Parrill AL, Quarles LD, (2010) GPRC6A mediates the non-genomic effects of steroids. J Biol Chem 285: 39953-39964.
36. Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, et al. (2008) Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin Exp Metastasis 25: 377-388.
37. Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Pratcorona M, Abbas S, et al. (2011) NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 118: 3645-3656.
38. Matsuyama T, Ishikawa T, Mogushi K, Yoshida T, Iida S, et al. (2010) MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Int J Cancer 127: 2292-2299.
39. Kote-Jarai Z, Amin Al Olama A, Leongamornlert D, Tymrakiewicz M, Saunders E, et al. (2011) Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet 129: 687-694.
40. Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, et al. (2011) Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 104: 535-542.
41. King MC, Marks JH, Mandell JB, (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302: 643-646.
42. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
43. Yang J, Lee SH, Goddard ME, Visscher PM, (2011) GCTA: A Tool for Genome-wide Complex Trait Analysis. The American Journal of Human Genetics 88: 76-82.
44. Kimura M, (1983) Rare variant alleles in the light of the neutral theory. Mol Biol Evol 1: 84-93.
45. Kolonel LN, Henderson BE, Hankin JH, Nomura AMY, Wilkens LR, et al. (2000) A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. American Journal of Epidemiology 151: 346-357.
46. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
47. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904-909.
48. Hauck W, Donner A, (1977) Wald's Test as Applied to Hypotheses in Logit Analysis. JASA 72: 851-853.